.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AR13_LamivudineAbacavirAndDolutegravi.LamivudineAbacavirAndDolutegravi

Information

name:LamivudineAbacavirAndDolutegravir
ATC code:J05AR13
route:oral
n-compartments1

The fixed-dose combination of lamivudine, abacavir, and dolutegravir is an oral antiretroviral medication used for the treatment of HIV-1 infection in adults and adolescents. It is currently approved and widely used as a complete regimen in HIV management. Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTIs), while dolutegravir is an integrase strand transfer inhibitor (INSTI).

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers after oral administration of the fixed-dose combination (Triumeq).

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos